<SEC-DOCUMENT>0001628280-17-005923-index.html : 20170525
<SEC-HEADER>0001628280-17-005923.hdr.sgml : 20170525
<ACCEPTANCE-DATETIME>20170525165656
ACCESSION NUMBER:		0001628280-17-005923
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		3
REFERENCES 429:			333-189965
REFERENCES 429:			333-196487
FILED AS OF DATE:		20170525
DATE AS OF CHANGE:		20170525
EFFECTIVENESS DATE:		20170525

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mirati Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001576263
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				462693615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-218239
		FILM NUMBER:		17870765

	BUSINESS ADDRESS:	
		STREET 1:		9393 TOWNE CENTRE DRIVE
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-332-3410

	MAIL ADDRESS:	
		STREET 1:		9393 TOWNE CENTRE DRIVE
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>forms-8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: forms-8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>exhibit51legalopinion.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
Document 2 - file: exhibit51legalopinion.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>exhibit231eyconsent.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
Document 3 - file: exhibit231eyconsent.htm

</DOCUMENT>
</SEC-DOCUMENT>